SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-22-027827
Filing Date
2022-10-06
Accepted
2022-10-06 17:00:13
Documents
13
Period of Report
2022-09-20
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 37642
2 ex16-1.htm EX-16.1 4935
  Complete submission text file 0001493152-22-027827.txt   218756

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE envb-20220920.xsd EX-101.SCH 3224
4 XBRL LABEL FILE envb-20220920_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE envb-20220920_pre.xml EX-101.PRE 22357
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 3857
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38286 | Film No.: 221298639
SIC: 2834 Pharmaceutical Preparations